● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

MEDANTA

BSE
Global Health Limited
Healthcare· Healthcare Services· INE474Q01031· Scrip: 543654
ENहिन्दीગુજરાતીमराठी
1,224.10
18.00 (+0.00%)
2026-06-10
BSE
1,224.10
18.00
+0.00%
9691,0851,2021,3181,43406-1908-1210-0812-0301-2903-2706-0306-10
230 trading days · 1Y period
TODAY (BSE)
Open1,234.85
High1,255.65
Low1,215.70
Prev Close1,242.10
Volume6,457
Value₹0.8Cr
L: 1,215.70H: 1,255.65
Info
Face Value₹2
Listed2022-11-16
ISININE474Q01031
SeriesA
BSE Scrip543654

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-1.37%
PAT+9.20%
EPS+9.24%
Profitability
Dividend
TTM Revenue
₹3570 Cr
TTM EBITDA
₹1065 Cr
TTM PAT
₹507 Cr
TTM EPS
₹18.89
Rev/Share
₹132.8

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr239 Cr478 Cr717 Cr957 Cr23-0323-0623-0923-1224-0324-0624-0924-123.83.84.74.64.74.04.95.3
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31943 Cr770 Cr300 Cr189 Cr143 Cr5.32
2024-09-30957 Cr794 Cr297 Cr181 Cr131 Cr4.87
2024-06-30861 Cr739 Cr246 Cr144 Cr106 Cr3.96
2024-03-31809 Cr693 Cr223 Cr143 Cr127 Cr4.74
2023-12-31833 Cr682 Cr283 Cr172 Cr124 Cr4.61
2023-09-30844 Cr694 Cr279 Cr171 Cr125 Cr4.66
2023-06-30773 Cr653 Cr238 Cr141 Cr102 Cr3.80
2023-03-31703 Cr599 Cr224 Cr133 Cr101 Cr3.77

Shareholding Pattern

CURRENT2026-03-31
33.0%PROMOTER
Promoter33.0%
FII10.2%
DII14.8%
Public66.9%
PROMOTER HOLDING TREND
33.0%24-0633.0%24-0933.0%24-1233.0%25-0333.0%25-0933.0%25-1233.0%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-22DividendDividend - Re 0.50 Per Share

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-101,245.001,256.201,215.101,225.5090,871
2026-06-031,209.001,218.301,195.001,201.304.07L
2026-05-271,238.001,238.001,202.501,207.801.49L
2026-05-261,256.701,259.001,223.001,228.802.22L
2026-05-251,254.701,266.501,236.601,249.301.28L
2026-05-221,240.201,250.001,231.301,238.1075,889
2026-05-211,254.501,255.001,228.201,240.2077,180
2026-05-201,244.001,249.001,221.301,240.101.49L
2026-05-191,240.001,259.301,218.101,240.404.04L
2026-05-181,242.901,253.401,220.201,239.202.52L
2026-05-151,234.001,278.001,220.901,242.507.81L
2026-05-141,201.201,241.801,194.401,211.905.90L
2026-05-131,187.201,210.601,165.301,196.004.32L
2026-05-121,239.201,240.401,186.401,193.108.53L
2026-05-111,194.601,248.901,185.201,239.203.11L
2026-05-081,213.901,214.901,182.801,200.602.28L
2026-05-071,185.601,226.901,185.601,206.902.40L
2026-05-061,185.001,191.201,170.201,181.601.04L
2026-05-051,169.501,179.901,159.201,170.2059,061
2026-05-041,116.201,183.101,112.101,171.504.31L
2026-04-301,130.001,143.051,112.151,117.252.77L
2026-04-291,143.001,171.451,132.251,142.951.17L
2026-04-281,167.101,179.001,132.851,137.551.32L
2026-04-271,105.551,175.001,102.101,167.802.20L
2026-04-241,100.351,117.751,095.601,105.5576,612
2026-04-231,115.001,129.501,102.201,111.351.20L
2026-04-221,085.001,114.851,078.601,111.852.20L
2026-04-211,075.901,092.001,075.901,081.3064,070
2026-04-201,089.801,104.901,075.001,079.3579,240
2026-04-171,095.001,095.001,068.601,089.401.84L

Frequently Asked Questions

About

Global Health Limited, formerly known as Global Health Private Limited, is an India-based tertiary healthcare provider operating in the North and East regions through its network of five hospitals in cities like Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow. The company offers advanced, end-to-end healthcare services across specialties including digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, and more. Notably, it has been recognized for its strong R&D pipeline and focus on providing high-quality medical treatments.

BOARD OF DIRECTORS

Mutual Fund Holdings

2 funds · bar length = % to NAVBrowse all funds →
hdfc1 scheme
HDFC NIFTY MIDCAP 150 INDEX FUND
0.23%
₹1 Cr
baroda1 scheme
Baroda BNP Paribas NIFTY Midcap 150 Index Fund
0.00%
₹0 Cr